Global Veterinary Drug Market Growth 2023-2029

Publisher Name :
Date: 09-Jan-2023
No. of pages: 114

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

LPI (LP Information)' newest research report, the "Veterinary Drug Industry Forecast" looks at past sales and reviews total world Veterinary Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Drug sales for 2023 through 2029. With Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug.

The global Veterinary Drug market size is projected to grow from US$ 23200 million in 2022 to US$ 34220 million in 2029; it is expected to grow at a CAGR of 34220 from 2023 to 2029.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Anti-Infectives

- Anti-Inflammatory

- Parasiticides

- Analgesics

- Sedatives

- Others

Segmentation by application

- Pets

- Cattle

- Poultry

- Swine

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Zoetis

- Elanco

- Boehringer Ingelheim

- Merck

- Virbac

- Ceva

- Vetoquinol

- Dechra

- Norbrook

- Phibro

- Huvepharma

- Hipra

- Ouro Fino Saude

- CAHIC

- Orion

- Ringpu Biology

- Nippon Zenyaku Kogyo

- Farmavet-Pasteur

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Drug market?

What factors are driving Veterinary Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Drug market opportunities vary by end market size?

How does Veterinary Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Veterinary Drug Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Drug by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Veterinary Drug Sales by Type
2.3.1 Global Veterinary Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Drug Sale Price by Type (2018-2023)
2.4 Veterinary Drug Segment by Application
2.4.1 Pets
2.4.2 Cattle
2.4.3 Poultry
2.4.4 Swine
2.4.5 Others
2.5 Veterinary Drug Sales by Application
2.5.1 Global Veterinary Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Drug Sale Price by Application (2018-2023)
3 Global Veterinary Drug by Company
3.1 Global Veterinary Drug Breakdown Data by Company
3.1.1 Global Veterinary Drug Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Drug Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Drug Revenue by Company (2018-2023)
3.2.2 Global Veterinary Drug Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Drug Product Location Distribution
3.4.2 Players Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Drug by Geographic Region
4.1 World Historic Veterinary Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Drug Sales Growth
4.4 APAC Veterinary Drug Sales Growth
4.5 Europe Veterinary Drug Sales Growth
4.6 Middle East & Africa Veterinary Drug Sales Growth
5 Americas
5.1 Americas Veterinary Drug Sales by Country
5.1.1 Americas Veterinary Drug Sales by Country (2018-2023)
5.1.2 Americas Veterinary Drug Revenue by Country (2018-2023)
5.2 Americas Veterinary Drug Sales by Type
5.3 Americas Veterinary Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Drug Sales by Region
6.1.1 APAC Veterinary Drug Sales by Region (2018-2023)
6.1.2 APAC Veterinary Drug Revenue by Region (2018-2023)
6.2 APAC Veterinary Drug Sales by Type
6.3 APAC Veterinary Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Drug by Country
7.1.1 Europe Veterinary Drug Sales by Country (2018-2023)
7.1.2 Europe Veterinary Drug Revenue by Country (2018-2023)
7.2 Europe Veterinary Drug Sales by Type
7.3 Europe Veterinary Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Drug by Country
8.1.1 Middle East & Africa Veterinary Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Drug Sales by Type
8.3 Middle East & Africa Veterinary Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Drug
10.3 Manufacturing Process Analysis of Veterinary Drug
10.4 Industry Chain Structure of Veterinary Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Drug Distributors
11.3 Veterinary Drug Customer
12 World Forecast Review for Veterinary Drug by Geographic Region
12.1 Global Veterinary Drug Market Size Forecast by Region
12.1.1 Global Veterinary Drug Forecast by Region (2024-2029)
12.1.2 Global Veterinary Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Drug Forecast by Type
12.7 Global Veterinary Drug Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Veterinary Drug Product Portfolios and Specifications
13.1.3 Zoetis Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Veterinary Drug Product Portfolios and Specifications
13.2.3 Elanco Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Drug Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Veterinary Drug Product Portfolios and Specifications
13.4.3 Merck Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Veterinary Drug Product Portfolios and Specifications
13.5.3 Virbac Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Ceva
13.6.1 Ceva Company Information
13.6.2 Ceva Veterinary Drug Product Portfolios and Specifications
13.6.3 Ceva Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ceva Main Business Overview
13.6.5 Ceva Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Veterinary Drug Product Portfolios and Specifications
13.7.3 Vetoquinol Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Dechra
13.8.1 Dechra Company Information
13.8.2 Dechra Veterinary Drug Product Portfolios and Specifications
13.8.3 Dechra Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dechra Main Business Overview
13.8.5 Dechra Latest Developments
13.9 Norbrook
13.9.1 Norbrook Company Information
13.9.2 Norbrook Veterinary Drug Product Portfolios and Specifications
13.9.3 Norbrook Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Norbrook Main Business Overview
13.9.5 Norbrook Latest Developments
13.10 Phibro
13.10.1 Phibro Company Information
13.10.2 Phibro Veterinary Drug Product Portfolios and Specifications
13.10.3 Phibro Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Phibro Main Business Overview
13.10.5 Phibro Latest Developments
13.11 Huvepharma
13.11.1 Huvepharma Company Information
13.11.2 Huvepharma Veterinary Drug Product Portfolios and Specifications
13.11.3 Huvepharma Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Huvepharma Main Business Overview
13.11.5 Huvepharma Latest Developments
13.12 Hipra
13.12.1 Hipra Company Information
13.12.2 Hipra Veterinary Drug Product Portfolios and Specifications
13.12.3 Hipra Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hipra Main Business Overview
13.12.5 Hipra Latest Developments
13.13 Ouro Fino Saude
13.13.1 Ouro Fino Saude Company Information
13.13.2 Ouro Fino Saude Veterinary Drug Product Portfolios and Specifications
13.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ouro Fino Saude Main Business Overview
13.13.5 Ouro Fino Saude Latest Developments
13.14 CAHIC
13.14.1 CAHIC Company Information
13.14.2 CAHIC Veterinary Drug Product Portfolios and Specifications
13.14.3 CAHIC Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CAHIC Main Business Overview
13.14.5 CAHIC Latest Developments
13.15 Orion
13.15.1 Orion Company Information
13.15.2 Orion Veterinary Drug Product Portfolios and Specifications
13.15.3 Orion Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Orion Main Business Overview
13.15.5 Orion Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Veterinary Drug Product Portfolios and Specifications
13.16.3 Ringpu Biology Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Nippon Zenyaku Kogyo
13.17.1 Nippon Zenyaku Kogyo Company Information
13.17.2 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolios and Specifications
13.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Nippon Zenyaku Kogyo Main Business Overview
13.17.5 Nippon Zenyaku Kogyo Latest Developments
13.18 Farmavet-Pasteur
13.18.1 Farmavet-Pasteur Company Information
13.18.2 Farmavet-Pasteur Veterinary Drug Product Portfolios and Specifications
13.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Farmavet-Pasteur Main Business Overview
13.18.5 Farmavet-Pasteur Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Veterinary Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Anti-Inflammatory
Table 5. Major Players of Parasiticides
Table 6. Major Players of Analgesics
Table 7. Major Players of Sedatives
Table 8. Major Players of Others
Table 9. Global Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 10. Global Veterinary Drug Sales Market Share by Type (2018-2023)
Table 11. Global Veterinary Drug Revenue by Type (2018-2023) & ($ million)
Table 12. Global Veterinary Drug Revenue Market Share by Type (2018-2023)
Table 13. Global Veterinary Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 14. Global Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 15. Global Veterinary Drug Sales Market Share by Application (2018-2023)
Table 16. Global Veterinary Drug Revenue by Application (2018-2023)
Table 17. Global Veterinary Drug Revenue Market Share by Application (2018-2023)
Table 18. Global Veterinary Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 19. Global Veterinary Drug Sales by Company (2018-2023) & (M Units)
Table 20. Global Veterinary Drug Sales Market Share by Company (2018-2023)
Table 21. Global Veterinary Drug Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Veterinary Drug Revenue Market Share by Company (2018-2023)
Table 23. Global Veterinary Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 24. Key Manufacturers Veterinary Drug Producing Area Distribution and Sales Area
Table 25. Players Veterinary Drug Products Offered
Table 26. Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Veterinary Drug Sales by Geographic Region (2018-2023) & (M Units)
Table 30. Global Veterinary Drug Sales Market Share Geographic Region (2018-2023)
Table 31. Global Veterinary Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Veterinary Drug Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Veterinary Drug Sales by Country/Region (2018-2023) & (M Units)
Table 34. Global Veterinary Drug Sales Market Share by Country/Region (2018-2023)
Table 35. Global Veterinary Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Veterinary Drug Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 38. Americas Veterinary Drug Sales Market Share by Country (2018-2023)
Table 39. Americas Veterinary Drug Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Veterinary Drug Revenue Market Share by Country (2018-2023)
Table 41. Americas Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 42. Americas Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 43. APAC Veterinary Drug Sales by Region (2018-2023) & (M Units)
Table 44. APAC Veterinary Drug Sales Market Share by Region (2018-2023)
Table 45. APAC Veterinary Drug Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Veterinary Drug Revenue Market Share by Region (2018-2023)
Table 47. APAC Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 48. APAC Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 49. Europe Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 50. Europe Veterinary Drug Sales Market Share by Country (2018-2023)
Table 51. Europe Veterinary Drug Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Veterinary Drug Revenue Market Share by Country (2018-2023)
Table 53. Europe Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 54. Europe Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 55. Middle East & Africa Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 56. Middle East & Africa Veterinary Drug Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Veterinary Drug Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Veterinary Drug Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 60. Middle East & Africa Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 61. Key Market Drivers & Growth Opportunities of Veterinary Drug
Table 62. Key Market Challenges & Risks of Veterinary Drug
Table 63. Key Industry Trends of Veterinary Drug
Table 64. Veterinary Drug Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Veterinary Drug Distributors List
Table 67. Veterinary Drug Customer List
Table 68. Global Veterinary Drug Sales Forecast by Region (2024-2029) & (M Units)
Table 69. Global Veterinary Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Veterinary Drug Sales Forecast by Country (2024-2029) & (M Units)
Table 71. Americas Veterinary Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Veterinary Drug Sales Forecast by Region (2024-2029) & (M Units)
Table 73. APAC Veterinary Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Veterinary Drug Sales Forecast by Country (2024-2029) & (M Units)
Table 75. Europe Veterinary Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Veterinary Drug Sales Forecast by Country (2024-2029) & (M Units)
Table 77. Middle East & Africa Veterinary Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Veterinary Drug Sales Forecast by Type (2024-2029) & (M Units)
Table 79. Global Veterinary Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Veterinary Drug Sales Forecast by Application (2024-2029) & (M Units)
Table 81. Global Veterinary Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Zoetis Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Veterinary Drug Product Portfolios and Specifications
Table 84. Zoetis Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. Elanco Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Veterinary Drug Product Portfolios and Specifications
Table 89. Elanco Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. Elanco Main Business
Table 91. Elanco Latest Developments
Table 92. Boehringer Ingelheim Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Veterinary Drug Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Boehringer Ingelheim Main Business
Table 96. Boehringer Ingelheim Latest Developments
Table 97. Merck Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Veterinary Drug Product Portfolios and Specifications
Table 99. Merck Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Virbac Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Virbac Veterinary Drug Product Portfolios and Specifications
Table 104. Virbac Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. Virbac Main Business
Table 106. Virbac Latest Developments
Table 107. Ceva Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Ceva Veterinary Drug Product Portfolios and Specifications
Table 109. Ceva Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Ceva Main Business
Table 111. Ceva Latest Developments
Table 112. Vetoquinol Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Vetoquinol Veterinary Drug Product Portfolios and Specifications
Table 114. Vetoquinol Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Vetoquinol Main Business
Table 116. Vetoquinol Latest Developments
Table 117. Dechra Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Dechra Veterinary Drug Product Portfolios and Specifications
Table 119. Dechra Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Dechra Main Business
Table 121. Dechra Latest Developments
Table 122. Norbrook Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Norbrook Veterinary Drug Product Portfolios and Specifications
Table 124. Norbrook Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Norbrook Main Business
Table 126. Norbrook Latest Developments
Table 127. Phibro Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Phibro Veterinary Drug Product Portfolios and Specifications
Table 129. Phibro Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Phibro Main Business
Table 131. Phibro Latest Developments
Table 132. Huvepharma Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Huvepharma Veterinary Drug Product Portfolios and Specifications
Table 134. Huvepharma Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Huvepharma Main Business
Table 136. Huvepharma Latest Developments
Table 137. Hipra Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Hipra Veterinary Drug Product Portfolios and Specifications
Table 139. Hipra Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Hipra Main Business
Table 141. Hipra Latest Developments
Table 142. Ouro Fino Saude Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Ouro Fino Saude Veterinary Drug Product Portfolios and Specifications
Table 144. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Ouro Fino Saude Main Business
Table 146. Ouro Fino Saude Latest Developments
Table 147. CAHIC Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. CAHIC Veterinary Drug Product Portfolios and Specifications
Table 149. CAHIC Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. CAHIC Main Business
Table 151. CAHIC Latest Developments
Table 152. Orion Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Orion Veterinary Drug Product Portfolios and Specifications
Table 154. Orion Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Orion Main Business
Table 156. Orion Latest Developments
Table 157. Ringpu Biology Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Ringpu Biology Veterinary Drug Product Portfolios and Specifications
Table 159. Ringpu Biology Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 160. Ringpu Biology Main Business
Table 161. Ringpu Biology Latest Developments
Table 162. Nippon Zenyaku Kogyo Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolios and Specifications
Table 164. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 165. Nippon Zenyaku Kogyo Main Business
Table 166. Nippon Zenyaku Kogyo Latest Developments
Table 167. Farmavet-Pasteur Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. Farmavet-Pasteur Veterinary Drug Product Portfolios and Specifications
Table 169. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 170. Farmavet-Pasteur Main Business
Table 171. Farmavet-Pasteur Latest Developments
List of Figures
Figure 1. Picture of Veterinary Drug
Figure 2. Veterinary Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Drug Sales Growth Rate 2018-2029 (M Units)
Figure 7. Global Veterinary Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Anti-Infectives
Figure 10. Product Picture of Anti-Inflammatory
Figure 11. Product Picture of Parasiticides
Figure 12. Product Picture of Analgesics
Figure 13. Product Picture of Sedatives
Figure 14. Product Picture of Others
Figure 15. Global Veterinary Drug Sales Market Share by Type in 2022
Figure 16. Global Veterinary Drug Revenue Market Share by Type (2018-2023)
Figure 17. Veterinary Drug Consumed in Pets
Figure 18. Global Veterinary Drug Market: Pets (2018-2023) & (M Units)
Figure 19. Veterinary Drug Consumed in Cattle
Figure 20. Global Veterinary Drug Market: Cattle (2018-2023) & (M Units)
Figure 21. Veterinary Drug Consumed in Poultry
Figure 22. Global Veterinary Drug Market: Poultry (2018-2023) & (M Units)
Figure 23. Veterinary Drug Consumed in Swine
Figure 24. Global Veterinary Drug Market: Swine (2018-2023) & (M Units)
Figure 25. Veterinary Drug Consumed in Others
Figure 26. Global Veterinary Drug Market: Others (2018-2023) & (M Units)
Figure 27. Global Veterinary Drug Sales Market Share by Application (2022)
Figure 28. Global Veterinary Drug Revenue Market Share by Application in 2022
Figure 29. Veterinary Drug Sales Market by Company in 2022 (M Units)
Figure 30. Global Veterinary Drug Sales Market Share by Company in 2022
Figure 31. Veterinary Drug Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Veterinary Drug Revenue Market Share by Company in 2022
Figure 33. Global Veterinary Drug Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Veterinary Drug Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Veterinary Drug Sales 2018-2023 (M Units)
Figure 36. Americas Veterinary Drug Revenue 2018-2023 ($ Millions)
Figure 37. APAC Veterinary Drug Sales 2018-2023 (M Units)
Figure 38. APAC Veterinary Drug Revenue 2018-2023 ($ Millions)
Figure 39. Europe Veterinary Drug Sales 2018-2023 (M Units)
Figure 40. Europe Veterinary Drug Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Veterinary Drug Sales 2018-2023 (M Units)
Figure 42. Middle East & Africa Veterinary Drug Revenue 2018-2023 ($ Millions)
Figure 43. Americas Veterinary Drug Sales Market Share by Country in 2022
Figure 44. Americas Veterinary Drug Revenue Market Share by Country in 2022
Figure 45. Americas Veterinary Drug Sales Market Share by Type (2018-2023)
Figure 46. Americas Veterinary Drug Sales Market Share by Application (2018-2023)
Figure 47. United States Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Veterinary Drug Sales Market Share by Region in 2022
Figure 52. APAC Veterinary Drug Revenue Market Share by Regions in 2022
Figure 53. APAC Veterinary Drug Sales Market Share by Type (2018-2023)
Figure 54. APAC Veterinary Drug Sales Market Share by Application (2018-2023)
Figure 55. China Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Veterinary Drug Sales Market Share by Country in 2022
Figure 63. Europe Veterinary Drug Revenue Market Share by Country in 2022
Figure 64. Europe Veterinary Drug Sales Market Share by Type (2018-2023)
Figure 65. Europe Veterinary Drug Sales Market Share by Application (2018-2023)
Figure 66. Germany Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Veterinary Drug Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Veterinary Drug Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Veterinary Drug Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Veterinary Drug Sales Market Share by Application (2018-2023)
Figure 75. Egypt Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Veterinary Drug Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Veterinary Drug in 2022
Figure 81. Manufacturing Process Analysis of Veterinary Drug
Figure 82. Industry Chain Structure of Veterinary Drug
Figure 83. Channels of Distribution
Figure 84. Global Veterinary Drug Sales Market Forecast by Region (2024-2029)
Figure 85. Global Veterinary Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Veterinary Drug Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Veterinary Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Veterinary Drug Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Veterinary Drug Revenue Market Share Forecast by Application (2024-2029)
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs